Bio Gene Technology Stock Price To Earnings To Growth
| BGT Stock | 0.04 0 5.00% |
Bio Gene Technology fundamentals help investors to digest information that contributes to Bio Gene's financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio Gene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio Gene stock.
Bio | Price To Earnings To Growth |
Bio Gene Technology Company Price To Earnings To Growth Analysis
Bio Gene's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Bio Gene Technology has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Chemicals sector and 100.0% lower than that of the Materials industry. The price to earnings to growth for all Australia stocks is 100.0% higher than that of the company.
Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Bio Fundamentals
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.45 | ||||
| Current Valuation | 5.44 M | ||||
| Shares Outstanding | 201.36 M | ||||
| Shares Owned By Insiders | 43.33 % | ||||
| Price To Book | 2.74 X | ||||
| Price To Sales | 417.67 X | ||||
| Revenue | 18.32 K | ||||
| Gross Profit | 222.1 K | ||||
| EBITDA | (2.97 M) | ||||
| Net Income | (2.41 M) | ||||
| Total Debt | 368.45 K | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (2.75 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Target Price | 0.37 | ||||
| Beta | 0.71 | ||||
| Market Capitalization | 7.65 M | ||||
| Total Asset | 3.16 M | ||||
| Retained Earnings | (19.64 M) | ||||
| Working Capital | 2.59 M | ||||
| Net Asset | 3.16 M |
About Bio Gene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Gene Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Gene Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bio Stock Analysis
When running Bio Gene's price analysis, check to measure Bio Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Gene is operating at the current time. Most of Bio Gene's value examination focuses on studying past and present price action to predict the probability of Bio Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Gene's price. Additionally, you may evaluate how the addition of Bio Gene to your portfolios can decrease your overall portfolio volatility.